Climb Bio, Inc. (CLYM): Total Assets
$167.74M
As of 2025-12-31
$246.29M
As of 2026-06-30
+7.5%
3-year compound annual growth
+46.8%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $167.74M | -22.8% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $217.19M | +96.6% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $110.47M | -18.2% | 2025-03-25, Balance as of period end |
| 2022-12-31 | $134.99M | -22.1% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $173.24M | +603.3% | 2023-03-06, Balance as of period end |
| 2020-12-31 | $24.63M | n/a | 2022-03-07, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | 2025-12-31 | $167.74M | -22.8% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | 2025-12-31 | $168.19M | +7.9% |
| Eledon Pharmaceuticals, Inc. (ELDN) | 2025-12-31 | $169.01M | -4.7% |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $166.13M | +32.5% |
| Apimeds Pharmaceuticals US, Inc. (APUS) | 2025-12-31 | $164.18M | n/m |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | $172.25M | -45.4% |
| Cypherpunk Technologies Inc. (CYPH) | 2025-12-31 | $163.18M | +232.2% |
| Transcode Therapeutics, Inc. (RNAZ) | 2025-12-31 | $162.40M | n/m |
| PepGen Inc. (PEPG) | 2025-12-31 | $173.91M | +15.3% |
Compare CLYM, CRBP, ELDN, GYRE side by side · Screen every company in Pharmaceutical Preparations ↗